by Anand Patadiya | Sep 17, 2024
Dr. Joseph Elassal serves as the Chief Medical Officer, where he is responsible for the strategy, direction, and execution of the company’s clinical development plans. Prior to joining Ankyra, Dr. Elassal most recently was Sr. Director in Oncology Medical Affairs for...
by Anand Patadiya | Sep 17, 2024
Mr. Gorgol brings over 40 years of experience in financial-focused roles across several industries, including nearly 25 years in life sciences and biotechnology. He joins Ankyra from Replimune, where he served as the chief accounting officer and was responsible for...
by Anand Patadiya | Sep 17, 2024
Ms. Gail Iodice serves as Vice President of Clinical Development, where she works with the Clinical Team to provide clinical guidance, translational direction, and executes on strategies to evaluate new drugs and clinical trials. She brings with her extensive clinical...
by Anand Patadiya | Sep 17, 2024
Dr. Kanika Jain is a Scientist at Ankyra where she is working to expand and advance the company’s pre-clinical pipeline of immunomodulatory agents. Prior to Ankyra, she was a Scientist at Moderna, working in discovery research as part of their Immuno-Oncology team....
by Anand Patadiya | Sep 17, 2024
Dr. Howard L. Kaufman has served as the President and Chief Executive Officer since March 2022. He joined the company in 2021 as the Chief Medical Officer. Dr. Kaufman is a leading authority on local tumor immunotherapy and oncolytic viruses. He led the successful...
